Набор от данни:  Актуализация на регистрите на НСЦРЛП към 02.06.2020

одобрен

Приложение 4 на ПЛС от 02.06.2020 г.

Уникален идентификатор:  4ae0eb5e-4f0c-4e5f-b918-75e603e96e47

Текуща версия: 1

Показвана версия: 1

Формат: CSV

  • Създаден на: 2020-06-11 15:08:08
  • Създаден от: georgi_sivchev
  • Последна промяна: 2020-06-11 15:08:08
записа на страница
Подреди по:
Възходящ ред Низходящ ред

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Europe MA EEIG, Белгия Pfizer Manufacturing Belgium NV, Belgium 4834.36 966.87 5801.23 4% 10 4844.36 968.87 5813.23 16% 25 4869.36 973.87 5843.23 Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение 25.06.2018 02.12.2018 Неактивен 3301
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Europe MA EEIG, Белгия Pfizer Manufacturing Belgium NV, Belgium 3238.78 647.76 3886.54 4% 10 3248.78 649.76 3898.54 16% 25 3273.78 654.76 3928.54 Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 НСР-8981/14.04.2016.; НСР-17510/13.12.2018 28.12.2018 02.01.2019 Активен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Europe MA EEIG, Белгия Pfizer Manufacturing Belgium NV, Belgium 3238.78 647.76 3886.54 4% 10 3248.78 649.76 3898.54 16% 25 3273.78 654.76 3928.54 Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 НСР-8981/14.04.2016.; НСР-17510/13.12.2018 28.12.2018 02.01.2019 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Europe MA EEIG, Белгия Pfizer Manufacturing Belgium NV, Belgium 3251.12 650.22 3901.34 4% 10 3261.12 652.22 3913.34 16% 25 3286.12 657.22 3943.34 Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 НСР-8981/14.04.2016. 30.04.2016 02.12.2018 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3251.12 650.22 3901.34 4% 10 3261.12 652.22 3913.34 16% 25 3286.12 657.22 3943.34 Протокол №242/14.09.2017 НСР-8981/14.04.2016. 30.04.2016 02.10.2017 Неактивен 3300
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4834.36 966.87 5801.23 4% 10 4844.36 968.87 5813.23 16% 25 4869.36 973.87 5843.23 Протокол №242/14.09.2017 НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение 25.06.2018 02.08.2018 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4834.36 966.87 5801.23 4% 10 4844.36 968.87 5813.23 16% 25 4869.36 973.87 5843.23 Протокол №242/14.09.2017 НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение* 25.06.2018 02.07.2018 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4880.58 976.12 5856.7 4% 10 4890.58 978.12 5868.7 16% 25 4915.58 983.12 5898.7 Протокол №242/14.09.2017 НСР-8982/14.04.2016. 30.04.2016 02.10.2017 Неактивен 3301
Pegvisomant EU/1/02/240/003 Somavert, Powder for solution for injection, 20, mg, Pack: 30 Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 6919.96 1383.99 8303.95 4% 10 6929.96 1385.99 8315.95 16% 25 6954.96 1390.99 8345.95 цената се заличава КЦРР-2538/14.03.2013 КЦ-3163/04.11.2011 06.03.2013 06.03.2013 Заличен 1643
Pegvisomant EU/1/02/240/003 Somavert, Powder for solution for injection, 20, mg, Pack: 30 Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 7132.23 1426.45 8558.68 4% 10 7142.23 1428.45 8570.68 16% 25 7167.23 1433.45 8600.68 изготвено корекционно решение КЦ-670/06.03.2009 КЦ-575/23.02.2009 10.03.2009 10.03.2009 Неактивен 1643
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4880.58 976.12 5856.7 4% 10 4890.58 978.12 5868.7 16% 25 4915.58 983.12 5898.7 НСР-8982/14.04.2016. 30.04.2016 30.04.2016 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4902.09 980.42 5882.51 4% 10 4912.09 982.42 5894.51 16% 25 4937.09 987.42 5924.51 Прот. № 136/16.09.2015 НСР-6850/30.07.2015 14.08.2015 14.08.2015 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5062.69 1012.54 6075.23 4% 10 5072.69 1014.54 6087.23 16% 25 5097.69 1019.54 6117.23 НСР-4867/17.10.2014 03.11.2014 03.11.2014 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5121.16 1024.23 6145.39 4% 10 5131.16 1026.23 6157.39 16% 25 5156.16 1031.23 6187.39 НСР-2338/13.01.2014 28.01.2014 28.01.2014 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5265.64 1053.13 6318.77 4% 10 5275.64 1055.13 6330.77 16% 25 5300.64 1060.13 6360.77 КЦ-3163/04.11.2011 06.03.2013 06.03.2013 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5349.2 1069.84 6419.04 4% 10 5359.2 1071.84 6431.04 16% 25 5384.2 1076.84 6461.04 КЦ-575/23.02.2009 10.03.2009 10.03.2009 Неактивен 3301
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3251.12 650.22 3901.34 4% 10 3261.12 652.22 3913.34 16% 25 3286.12 657.22 3943.34 НСР-8981/14.04.2016. 30.04.2016 30.04.2016 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3266.02 653.2 3919.22 4% 10 3276.02 655.2 3931.22 16% 25 3301.02 660.2 3961.22 Прот. № 136/16.09.2015 НСР-6849/30.07.2015 14.08.2015 14.08.2015 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3383.76 676.75 4060.51 4% 10 3393.76 678.75 4072.51 16% 25 3418.76 683.75 4102.51 НСР-4868/17.10.2014 03.11.2014 03.11.2014 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3420.26 684.05 4104.31 4% 10 3430.26 686.05 4116.31 16% 25 3455.26 691.05 4146.31 НСР-2338/13.01.2014 28.01.2014 28.01.2014 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3459.98 692 4151.98 4% 10 3469.98 694 4163.98 16% 25 3494.98 699 4193.98 КЦ-3163/04.11.2011 06.03.2013 06.03.2013 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3566.1 713.22 4279.32 4% 10 3576.1 715.22 4291.32 16% 25 3601.1 720.22 4321.32 КЦ-575/23.02.2009 10.03.2009 10.03.2009 Неактивен 3300
Pegvisomant EU/1/02/240/004 Somavert, Powder for solution for injection, 20, mg, Pack: 1 Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 258.56 51.71 310.27 4% 10 268.56 53.71 322.27 16% 25 293.56 58.71 352.27 изготвено корекционно решение КЦ-670/06.03.2009; Цената е заличена с решение НСР-3241/14.04.2014 КЦ-575/23.02.2009 10.03.2009 10.03.2009 Заличен 542
Sulphur hexafluoride ЕU/1/01/177/002 Sono Vue, Powder and solvent for dispersion for injection, 8 μl/ml, -, Pack: 1 vial + 1 pre-filled syringe + 1 'MiniSpike' rec. device Bracco International B.V., Нидерландия Bracco Imaging S.p.A, Италия 102.43 20.49 122.92 4% 4.1 106.53 21.31 127.84 16% 16.39 122.92 24.58 147.5 НСР-4337/05.08.2014; НСР-9040/21.04.2016; НСР-11905/06.03.2017; НСР-15725/25.05.2018; НСР-18064/01.03.2019 16.03.2019 02.04.2019 Активен 3097
Sulphur hexafluoride ЕU/1/01/177/002 Sono Vue, Powder and solvent for dispersion for injection, 8 μl/ml, -, Pack: 1 vial + 1 pre-filled syringe + 1 'MiniSpike' rec. device Bracco International B.V., Нидерландия Bracco Imaging S.p.A, Италия 104.03 20.81 124.84 4% 4.16 108.19 21.64 129.83 16% 16.64 124.83 24.97 149.8 НСР-4337/05.08.2014; НСР-9040/21.04.2016; НСР-11905/06.03.2017; НСР-15725/25.05.2018 09.06.2018 02.07.2018 Неактивен 3097
Показва 14000 до 14024 от общо 17384 записа
Линк за сваляне в CSV формат: Копирай
Линк за сваляне в JSON формат: Копирай
Линк за сваляне в XML формат: Копирай
 

Моля изчакайте